Latest Coronavirus Disease COVID 19 News and Research
Medicaid mystery: Millions of enrollees haven’t materialized in California
The predictions were dire: Coronavirus lockdowns would put millions of Americans out of work, stripping them of their health insurance and pushing them into Medicaid, the health insurance program for low-income people.
Adjunct professors: Jobs are low on pay and health benefits with high COVID risk
David Chatfield feels he transitioned from an unstable career in graphic design to what is becoming an even more unpredictable one in academia.
Assessing the effectiveness of healthcare protocols in epidemics
In attempts to reduce the spread of SARS-CoV-2, different authorities have adopted a variety of non-pharmacological interventions (NPI).
Free SaTScan Software Rapidly Detects Emerging COVID-19 Hotspots in New York City
As an example of precision public health, a new study reports the successful detection of a potential new local COVID-19 case cluster.
Prednisone, Hydroxychloroquine Best Among COVID-19 Treatments, Claims Large Spanish Study
The COVID-19 pandemic has taken the lives of several hundred thousand people across the world. In Spain, a intense outbreak took a toll of over 28,000 lives.
States search for ways to deal with COVID-19 testing backlogs
States frustrated by private laboratories' increasingly long turnarounds for COVID-19 test results are scrambling to find ways to salvage their testing programs.
Neutralizing antibodies isolated from COVID-19 patients can quash SARS-CoV-2
Scientists across the globe are racing to study how antibodies can help suppress SARS-CoV-2, the virus that causes the coronavirus disease (COVID-19).
Study shows interferons do not induce the expression of SARS-CoV-2 cell entry receptor
In a new bioRxiv study, authors identified a isoform of ACE2 (designated as deltaACE2 or dACE2) receptor, shown to be induced in various human cell types.
Disinfection of drinking water using UV light
While awaiting full access to their labs due to COVID-19 restrictions, scientists at the National Institute of Standards and Technology have taken this rare opportunity to report the technical details of pioneering research they conducted on the disinfection of drinking water using ultraviolet light.
New collaboration brings over 20,000 onsite COVID-19 tests to Detroit’s residents
A partnership among Altimetrik, a Southfield-based fast-growing global business transformation company, the 501(c)(3) Vattikutti Foundation, Henry Ford Health System and the City of Detroit has provided more than 20,000 onsite COVID-19 tests to residents in 163 of Detroit's senior and congregate living facilities, as well as the city's first responders and essential workers.
Mysterious enzyme inhibits inflammation in blood vessels, LJI study shows
Scrape your knee, and you'll see some red puffiness appear around the injury. This is inflammation, and it is driven by the immune system.
._3D_illustration_-_Illustration_-_Tatiana_Shepeleva_A1_79968432b094431797eecf0996b132f8-150x125.jpg "Study shows antibodies drop sharply in first three months after mild COVID-19 cases")
Study shows antibodies drop sharply in first three months after mild COVID-19 cases
A study by UCLA researchers shows that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 -- the virus that causes the disease -- drop sharply over the first three months after infection, decreasing by roughly half every 73 days.
For-profit status of LTC homes is associated with more cases of COVID-19 outbreaks, deaths
For-profit status is associated with the extent of an outbreak of coronavirus disease 2019 (COVID-19) in long-term care (LTC) homes and the number of resident deaths from COVID-19, but not the likelihood of an outbreak, which was related to the infection rate in the surrounding local public health unit and the total number of beds in the home, found new research published in CMAJ (Canadian Medical Association Journal).
Arcturus and Duke-NUS announce approval of clinical trials for COVID-19 vaccine candidate
Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare diseases and vaccines, and Duke-NUS Medical School, Singapore's flagship research-intensive graduate entry medical school, today announced that the Clinical Trial Application for COVID-19 vaccine candidate LUNAR-COV19 has been approved to proceed by the Singapore Health Sciences Authority.
Report highlights the need to improve quality of care for high-risk veterans
Veterans who have served in the U.S. military since the 9/11 attacks have a high level of need for both substance use treatment and mental health care, yet many do not receive appropriate help for their co-occurring disorders, according to a new RAND Corporation report.
Georgia State researchers receive NSF grant to develop coronavirus test tools
Georgia State University researchers have received a one-year, $200,000 rapid response grant from the National Science Foundation to develop a tool to detect the presence of SARS-CoV-2, the virus causing the COVID-19 pandemic.
Malaria drug does not prevent infection of human lung cells with novel coronavirus
More than 600,000 people worldwide have fallen victim to the lung disease COVID-19 so far, which is caused by the SARS coronavirus-2 (SARS-CoV-2).
Researchers win grant to study why COVID-19 patients lose their sense of smell
Researchers at the University of Colorado Anschutz Medical Campus have won a grant to study why many infected with Covid-19 lose their sense of smell.
Scientists want to know more about using UV light to fight COVID-19 spread
High up near the ceiling, in the dining room of his Seattle-area restaurant, Musa Firat recently installed a “killing zone” — a place where swaths of invisible electromagnetic energy penetrate the air, ready to disarm the coronavirus and other dangerous pathogens that drift upward in tiny, airborne particles.
Essential and in danger: Coronavirus sickens, even kills public health workers
As a veteran public health worker, Chantee Mack knew the coronavirus could kill. She already faced health challenges and didn't want to take any chances during the pandemic. So she asked — twice — for permission to work from home.
No hay comentarios:
Publicar un comentario